Glenmark Pharmaceuticals informs about closure of trading window

30 Oct 2024 Evaluate
Glenmark Pharmaceuticals has informed regarding the closure of trading window from September 30, 2024 to November 16, 2024 for the purpose of approval of Unaudited Financial Results for the second quarter and half year ended September 30, 2024.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1480.05 14.75 (1.01%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.